People · Operator
Named in public records as an officer, director or promoter · active 2015–2017 · Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Monopar Therapeutics | — | Biotechnology | Series A | $19.6M | $361.5M | 2015 |
Andrew P. Mazar at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Andrew P. Mazar on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Michael J. Brown | 1 | 6 |
| Christopher M. Starr | 1 | 3 |
| Raymond W. Anderson | 1 | 3 |
| Chandler D. Robinson | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.